acetaminophen has been researched along with Hyperlipemia in 4 studies
Acetaminophen: Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage.
paracetamol : A member of the class of phenols that is 4-aminophenol in which one of the hydrogens attached to the amino group has been replaced by an acetyl group.
Excerpt | Relevance | Reference |
---|---|---|
"We evaluated the effect of hemolysis, icterus and lipemia on 3 acetaminophen assays: namely the Syva® EMIT®, the Microgenics DRI® assay, and the Roche assay on a Roche Cobas® c501 or an Integra 800 analyzer." | 7.88 | Effect of hemolysis, icterus, and lipemia on three acetaminophen assays: Potential medical consequences of false positive results. ( Fan, SL; Kellogg, MD; Zhang, YV, 2018) |
"We compared the COBAS(R) acetaminophen and salicylate assays (Roche Diagnostics) with the Stanbio GDS assays (Stanbio Laboratories) that are currently used in our laboratory with respect to interferences from hemolysis and lipemia." | 7.74 | Effects of hemolysis and lipemia on the COBAS salicylate and acetaminophen assays compared to GDS assays. ( Clarke, W; Meany, D; Schowinsky, J, 2008) |
"We evaluated the effect of hemolysis, icterus and lipemia on 3 acetaminophen assays: namely the Syva® EMIT®, the Microgenics DRI® assay, and the Roche assay on a Roche Cobas® c501 or an Integra 800 analyzer." | 3.88 | Effect of hemolysis, icterus, and lipemia on three acetaminophen assays: Potential medical consequences of false positive results. ( Fan, SL; Kellogg, MD; Zhang, YV, 2018) |
"We compared the COBAS(R) acetaminophen and salicylate assays (Roche Diagnostics) with the Stanbio GDS assays (Stanbio Laboratories) that are currently used in our laboratory with respect to interferences from hemolysis and lipemia." | 3.74 | Effects of hemolysis and lipemia on the COBAS salicylate and acetaminophen assays compared to GDS assays. ( Clarke, W; Meany, D; Schowinsky, J, 2008) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Theodosis-Nobelos, P | 1 |
Athanasekou, C | 1 |
Rekka, EA | 1 |
Zhang, YV | 1 |
Fan, SL | 1 |
Kellogg, MD | 1 |
Meany, D | 1 |
Schowinsky, J | 1 |
Clarke, W | 1 |
Raghavendran, HR | 1 |
Sathivel, A | 1 |
Devaki, T | 1 |
4 other studies available for acetaminophen and Hyperlipemia
Article | Year |
---|---|
Dual antioxidant structures with potent anti-inflammatory, hypolipidemic and cytoprotective properties.
Topics: Acetaminophen; Animals; Anti-Inflammatory Agents; Antioxidants; Butanes; Carrageenan; Chemical and D | 2017 |
Effect of hemolysis, icterus, and lipemia on three acetaminophen assays: Potential medical consequences of false positive results.
Topics: Acetaminophen; False Positive Reactions; Hemolysis; Humans; Hyperlipidemias; Jaundice | 2018 |
Effects of hemolysis and lipemia on the COBAS salicylate and acetaminophen assays compared to GDS assays.
Topics: Acetaminophen; Biological Assay; Hemolysis; Humans; Hyperlipidemias; Reproducibility of Results; Sal | 2008 |
Effect of Sargassum polycystum (Phaeophyceae)-sulphated polysaccharide extract against acetaminophen-induced hyperlipidemia during toxic hepatitis in experimental rats.
Topics: Acetaminophen; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemical and Drug Induced Liver Inj | 2005 |